Implantica AG (publ) announces that Dr. med. Zehetner, Prof. (USC) from Switzerland, presented Klinik Beau-Site's RefluxStop results at Digestive Disease Week (DDW) 6-9 May, in Chicago, U.S., the world's premier meeting for gastrointestinal professionals. Dr. med.
Jörg Zehetner, Prof. (USC), surgeon at the Hirslanden Klinik Beau-Site Bern, Switzerland, highlighted the unique advantages of the RefluxStop therapy in the reflux patient population that have Ineffective Esophageal Motility (IEM), a disorder that often causes swallowing difficulties and pain, a patient group which does not have any optimal treatment options today. Encircling the food passageway as in existing treatments often worsen these patients' swallowing difficulties and Dr. Zehetner sees RefluxStop as a potential major breakthrough for these patients. Despite the IEM condition in this group of 20 patients, all patients are showing complete resolution or significant improvement of reflux symptoms.